Evidence map›Paper›PMID 32960910›Full record

Observational studyPloS one2020

CD32 is enriched on CD4dimCD8bright T cells.

Amber K Virdi, Jennillee Wallace, Hannah Barbian, Maureen H Richards, Ethan M Ritz, Beverly Sha, Lena Al-Harthi

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.Advances in experimental medicine and biology · 2024
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Amber K VirdiDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America.
Jennillee WallaceDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America.
Hannah BarbianDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America.
Maureen H RichardsDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America.
Ethan M RitzBiostatistics and Bioinformatics Core, Rush University Medical Center, Chicago, IL, United States of America.ORCID 0000-0002-8971-4549
Beverly ShaInfectious Diseases Division, Rush Medical College, Chicago, IL, United States of America.
Lena Al-HarthiDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, United States of America.ORCID 0000-0003-3915-3904
Rush University Medical Center · US

Funding

Understanding evoked and resting-state fMRI through multi scale imagingR01MH111424 · NIMH · YALE UNIVERSITY · PI CONSTABLE, R TODD, CRAIR, MICHAEL C. · 2016 to 2020
$5.2M
Neuroimmune axis in HAND and HIV persistence in the brainR01MH113425 · NIMH · RUSH UNIVERSITY MEDICAL CENTER · PI AL-HARTHI, LENA · 2017 to 2021
$3.1M
Social Skills Coach: An innovative multi-platform device to address social impairments among individuals with schizophreniaR43MH113424 · NIMH · C4 INNOVATIONS, LLC · PI FERREIRA, KATHLEEN, GOLDBERG, RICHARD WARREN · 2017 to 2017
$227k
NIMH NIH HHS R01 MH111424NIMH NIH HHS R01 MH113425NIMH NIH HHS R43 MH113424
6 · The paper itself

Abstract

CD4dimCD8bright T cells, a genuine population of CD8+ T cells, are highly activated and cytolytic. Recently, the low affinity IgG Fc fragment receptor CD32a was described as marker of HIV latency while others reported that CD32a is associated with T cell activation. Given that we have previously established that CD4dimCD8bright T cells are highly activated, mediate anti-HIV responses, and are infected by HIV, we assessed here CD32 expression on CD4dimCD8bright T cells in context of HIV. CD32 frequency on peripheral CD4dimCD8bright and CD4+ T cells was determined by flow cytometry among HIV negative and HIV positive patients. We report that among HIV- individuals, mean CD32 percent expression was 60% on CD4dimCD8bright T cells and 17% on CD4+ T cells (p<0.01). Among HIV+ patients, mean CD32 percent expression was 54% on CD4dimCD8bright T cells and 12% on CD4+ T cells (p<0.001). CD32 expression on CD4dimCD8bright T cells did not correlate with CD4 count and viral load and was not different by HIV serostatus. CD32 was also higher on other double positive T cell populations in both HIV negative and HIV positive donors in comparison to their single positive T cell counterpart. Together, these studies indicate that CD32 is enriched on double positive T cells regardless of HIV serostatus. The functional role of CD32 on these double positive T cells remains to be elucidated.

Indexed as

Anti-HIV AgentsCD4 Lymphocyte CountCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell SeparationFlow CytometryHIV-1HIV InfectionsHumansReceptors, IgGT-Lymphocyte SubsetsViral LoadAnti-HIV AgentsFCGR2A protein, humanReceptors, IgG

Identifiers

PMID32960910
PMCPMC7508398
OpenAlexW3089188730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.